Results 151 to 160 of about 2,048,259 (212)
Marrow iron staining should always be performed to diagnose Myelodysplastic/myeloproliferative neoplasia with ring sideroblasts and thrombocythemia. [PDF]
Chauffaille MLLF +2 more
europepmc +1 more source
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. [PDF]
Berger G +15 more
europepmc +1 more source
Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts. [PDF]
Martín I +13 more
europepmc +1 more source
Case Report: A Previously Healthy Young Woman With Lethal, Unremitting Metabolic Acidosis: Could a Novel Variant in <i>ALAS2</i> Be the Culprit? [PDF]
Brown G, Brown S.
europepmc +1 more source
Refractory Anemia With Ring Sideroblasts
Refractory anemia with ring sideroblasts (RARS) is a subtype of myelodysplastic syndrome (MDS) characterized by 15% or more ring sideroblasts in the bone marrow according to the WHO classification. After Perls staining, ring sideroblasts are defined as erythroblasts in which there are 5 or more siderotic granules covering at least a third of the ...
Mario Cazzola, Luca Malcovati
exaly +6 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Myelodysplastic syndromes with ring sideroblasts
Hematological Oncology, 2023Abstract Myelodysplastic syndromes (MDS) are acquired bone marrow malignant disorders characterized by ineffective hematopoiesis, resulting from a complex interaction between genetic and epigenetic mutations, alterations of the marrow microenvironment, and the immune system. In 2001, the World Health Organization (
Antonella Bruzzese +12 more
openaire +3 more sources

